Back

Smad7-based biologic targeting epidermis and stroma promotes healing of diabetic wounds in mice and pigs

Ke, Y.; Li, B.-Z.; Li, F.; Ravindran, R. K.; Wang, D.; Wang, S.; Hwang, S. T.; Simon, S.; Collins, S. R.; Young, C. D.; Wang, X.-J.

2026-01-02 immunology
10.64898/2025.12.31.697220 bioRxiv
Show abstract

This study aimed to identify novel mechanisms of diabetic wound healing defects and test a therapeutic intervention using diabetic mouse and pig models. We found Smad7 transgene expression in mouse epidermis promoted wound healing in diabetic mice. To isolate effects of Smad7 on wounds, we created a Smad7-based biologic (Tat-PYC-Smad7) that penetrated cells of the wound. Topical Tat-PYC-Smad7 treatment to diabetic pig and mouse wounds accelerated healing compared to vehicle controls. Tat-PYC-Smad7-treated wounds showed reduced TGF{beta}/NF{kappa}B signaling, faster re-epithelialization and better extracellular matrix remodeling. Tat-PYC-Smad7 also attenuated neutrophil NETosis, potentially acting through reductions in MPO enzymatic activity and MPO nuclear entry, consequently reducing chromatin decondensation and the release of NET components. Our study revealed that Tat-PYC-Smad7 promoted diabetic wound healing by targeting keratinocytes and neutrophils, providing insight into mechanisms of diabetic wound healing defects targetable by Smad7-based therapy.

Published in Nature Communications (predicted rank #8) · training set

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Matrix Biology
○ 29 papers in training set
Top 0.1%
12.9%
Similar papers in this journal
2
eLife
● 5828 papers in training set
Top 12%
9.1%
Similar papers in this journal
3
Scientific Reports
○ 3612 papers in training set
Top 6%
8.0%
Similar papers in this journal
4
iScience
○ 1154 papers in training set
Top 3%
4.4%
5
Journal of Investigative Dermatology
○ 49 papers in training set
Top 0.2%
4.4%
Similar papers in this journal
6
JCI Insight
● 277 papers in training set
Top 1%
4.4%
Similar papers in this journal
7
Frontiers in Immunology
○ 638 papers in training set
Top 3%
4.1%
Nature Communications · published here
○ 5641 papers in training set
Top 33%
3.6%
50% of probability mass above
9
The FASEB Journal
○ 194 papers in training set
Top 0.9%
3.5%
10
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 20%
2.5%
11
PLOS ONE
● 5266 papers in training set
Top 45%
1.8%
12
Molecular Therapy
○ 81 papers in training set
Top 0.8%
1.8%
13
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.3%
1.8%
14
Cell Death & Disease
147 papers in training set
Top 2%
1.8%
15
Journal of Clinical Investigation
● 179 papers in training set
Top 3%
1.5%
16
EMBO Molecular Medicine
○ 95 papers in training set
Top 1%
1.2%
17
Journal of Translational Medicine
○ 57 papers in training set
Top 1%
1.2%
18
PNAS Nexus
◐ 159 papers in training set
Top 2%
1.2%
19
Communications Biology
○ 993 papers in training set
Top 20%
1.2%
20
Cell Reports
○ 1498 papers in training set
Top 24%
1.1%
21
Disease Models & Mechanisms
139 papers in training set
Top 2%
1.1%
22
Science Advances
● 1243 papers in training set
Top 27%
1.1%
23
Journal of Virology
● 499 papers in training set
Top 3%
1.0%
24
Cell Reports Medicine
○ 153 papers in training set
Top 5%
0.9%
25
Arteriosclerosis, Thrombosis, and Vascular Biology
○ 71 papers in training set
Top 1%
0.9%
26
Advanced Science
○ 286 papers in training set
Top 9%
0.9%
27
Experimental & Molecular Medicine
○ 14 papers in training set
Top 0.2%
0.6%
28
Arthritis & Rheumatology
○ 36 papers in training set
Top 0.6%
0.6%
29
Cell Death Discovery
○ 58 papers in training set
Top 2%
0.6%
30
Cell Death & Differentiation
○ 48 papers in training set
Top 1%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.